SynchNeuro is a Boomerang Ventures Portfolio Company
Source: CityBiz
SynchNeuro, a Philadelphia-based health-technology startup, has received a seed investment from Boomerang Ventures, the companies said. Financial terms weren’t disclosed.
Boomerang Ventures, headquartered in Indianapolis, operates as both a venture studio and a fund, focusing on early-growth companies in connected health technology. The firm backs startups across a range of healthcare-tech domains, including value-based care, remote monitoring, med-tech devices, and digital health platforms.
Its portfolio includes companies such as:
- Aware Health, which provides musculoskeletal-care solutions aimed at reducing costs and unnecessary imaging.
- Pelvital USA, Inc. (branded “Flyte®”), a women’s-health med-tech company offering new treatment options for pelvic-floor disorders.
- Lizzy Care, which uses AI-driven analytics and real-time care coordination for dementia and memory-care at home.
- GEOH, a company focused on software and services for home-health-care agencies.
SynchNeuro plans to use the new investment to expand operations and accelerate the development of its real-time monitoring platform.
Founded by neurosurgeon Dr. Casey Halpern, SynchNeuro is developing a non-invasive system that decodes brain-signal activity (EEG) into cardiometabolic data. The technology interprets EEG readings to estimate glucose levels and other metabolic indicators, offering a potential alternative to traditional glucose monitors. The company says its platform is designed to give individuals with prediabetes or early-stage Type 2 diabetes more proactive insight into their metabolic health.
Source: CityBiz, November 25, 2025
